[1] 冯思,张理,谢威,等. ω-3PUFAs在调节结直肠癌发生发展中的研究进展[J].中南大学学报(医学版),2019,44:588-595. [2] De Freitas Rodrigues J, Philippsen HK, et al. The potential of DHA as cancer therapy strategies: a narrative review of in vitro cytotoxicity trials[J].Nutrients, 2023,15:2006. doi: 10.3390/nu15082006. [3] Narayanankutty, Arunaksharan. PI3K/Akt/mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence[J].Curr Drug Targets, 2019, 20: 1217-1226. [4] Shao X, Lei Z, Zhou C. NLRP3 promotes colorectal cancer cell proliferation and metastasis via regulating epithelial mesenchymal transformation[J].Anti-cancer Agent Me, 2020,20:820-827. [5] Liu Z, Li J, Shu L, et al. PI3K regulates the activation of NLRP3 inflammasome in atherosclerosis through part-dependent AKT signaling pathway[J].Exp Anim, 2021, 70: 488-497. [6] 何可,许庆文. n-3多不饱和脂肪酸及结直肠癌模型建立的研究现状[J].海南医学,2013,24:272-274. [7] Jayathilake AG, Luwor RB, Nurgali K, et al. Molecular mechanisms associated with the inhibitory role of long chain n-3 PUFA in colorectal cancer[J].Integr Cancer Ther, 2024, 23:15347354241243024. doi: 10.1177/15347354241243024. [8] Leiphrakpam PD,Are C. PI3K/Akt/mTOR signaling pathway as a target for colorectal cancer treatment[J].Int J Mol Sci, 2024, 25:3178.doi: 10.3390/ijms25063178. [9] Alzahrani AS. PI3K/Akt/mTOR inhibitors in cancer:at the bench and bedside[J].Semin Cancer Biol, 2019,59:125-132. [10] Zhan L, Su F, Li Q, et al. Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action[J]. Front Pharmacol,2023,14:1257450.doi: 10.3389/fphar.2023.1257450. [11] Kim N, Jeong S, Jing K, et al. Docosahexaenoic acid iInduces cell death in human non-small cell lung cancer cells by repressing mTOR via AMPK activation and PI3K/Akt inhibition[J]. Biomed Res Int,2015,2015:239764.doi:10.1155/2015/239764. [12] Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases[J].Nat Immunol, 2021,22:550-559. [13] Yao A,Chen J,Xu Y, et al. Endogenous n-3 polyunsaturated fatty acids prevent azoxymethane-induced colon tumorigenesis in mice fed a high-fat diet[J].J Funct Foods, 2018, 48. doi: 10.1016/j.jff.2018.07.042. [14] Dumont A, de Rosny C, Kieu TL, et al. Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC:implication in cancer treatment[J].Cell Death Dis,2019,10:485.doi: 10.1038/s41419-019-1723-x. [15] Qiu Y, Huang X, Huang L,et al. 5-HT(1A) receptor antagonist improves behavior performance of delirium rats through inhibiting PI3K/Akt/mTOR activation-induced NLRP3 activity[J].IUBMB Life, 2016, 68:311-319. |